BCL6B and cholangiocarcinoma: Data from The Cancer Genome Atlas (TCGA) reveal upregulated BCL6B expression in head and neck squamous cell carcinoma, cholangiocarcinoma, clear cell renal carcinoma, hepatocellular carcinoma, gastric cancer, thyroid cancer, and glioblastoma.